SCHEMBL4853528

SCHEMBL4853528

COc1ccc(/C=C/C(=O)c2cccc(OCCCN(C)C)c2)c(OC)c1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.56
CYP1A1 P04798 2/20 0.53
CYP1A2 P05177 2/20 0.53
CYP2D6 P10635 2/20 0.53
CYP1B1 Q16678 2/20 0.53
CYP3A4 P08684 1/20 0.53
KEAP1 Q14145 1/20 0.50
NFE2L2 Q16236 1/20 0.50
RELA Q04206 1/20 0.50
ALOX5 P09917 1/20 0.49
MAOB P27338 1/20 0.48
BCHE P06276 2/20 0.48
ACHE P22303 2/20 0.48
LMNA P02545 3/20 0.48
ALDH1A1 P00352 2/20 0.48
NTSR1 P30989 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
TP53 P04637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4852523 1.00 ABCG2 (0.56) ABCG2CYP1A1CYP1A2CYP2D6CYP1B1
SCHEMBL4846957 0.95 ABCG2 (0.57) ABCG2CYP1A1CYP1A2CYP2D6CYP1B1
SCHEMBL4853820 0.95 ABCG2 (0.57) ABCG2CYP1A1CYP1A2CYP2D6CYP1B1
SCHEMBL4854277 0.87 MAPT (0.61) ABCG2CYP1A1CYP1A2CYP2D6CYP1B1
SCHEMBL4853019 0.87 MAPT (0.61) ABCG2CYP1A1CYP1A2CYP2D6CYP1B1
SCHEMBL4857305 0.87 ABCG2 (0.59) ABCG2KEAP1NFE2L2MAOBBCHE
SCHEMBL4852947 0.87 ABCG2 (0.59) ABCG2KEAP1NFE2L2MAOBBCHE
SCHEMBL4846703 0.87 KEAP1 (0.65) CYP1A1CYP1A2CYP2D6CYP1B1CYP3A4
SCHEMBL4850077 0.87 KEAP1 (0.65) CYP1A1CYP1A2CYP2D6CYP1B1CYP3A4
SCHEMBL4855944 0.82 ABCG2 (0.69) ABCG2CYP1A1CYP1A2CYP2D6CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed